BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2542107)

  • 21. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan.
    Elsner M; Tiedge M; Guldbakke B; Munday R; Lenzen S
    Diabetologia; 2002 Nov; 45(11):1542-9. PubMed ID: 12436338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relative importance of cellular uptake and reactive oxygen species for the toxicity of alloxan and dialuric acid to insulin-producing cells.
    Elsner M; Gurgul-Convey E; Lenzen S
    Free Radic Biol Med; 2006 Sep; 41(5):825-34. PubMed ID: 16895803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanism of action of alloxan on pancreatic B-cells with special regard to the alloxan-metal-complex theory. II. Actions of alloxan, alloxanic acid, Zn2+ and ethyleneglycol-bis-(beta-aminoethylether)-N,N'tetraacetic acid (EGTA) on the assembly of microtubule proteins (MTP) into microtubules or MPT sheets in vitro].
    Schmidt R; Müller H; Unger E; Vater W
    Acta Histochem; 1990; 88(2):93-101. PubMed ID: 2120900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of adenosine cyclic monophosphate on insulin secretion in healthy rats and in those with alloxan diabetes].
    Kniazev IuA; Vakhrusheva LL; Golovanova VB; Zheltukov NS
    Probl Endokrinol (Mosk); 1980; 26(3):53-5. PubMed ID: 6250140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloxan-glucose interaction: effect on incorporation of 14C-leucine into pancreatic islets of rat.
    Bansal R; Ahmad N; Kidwai JR
    Acta Diabetol Lat; 1980; 17(2):135-43. PubMed ID: 7004041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on streptozotocin diabetes.
    Ganda OP; Rossini AA; Like AA
    Diabetes; 1976 Jul; 25(7):595-603. PubMed ID: 132382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of D-mannoheptulose on blood glucose and alloxan sensitivity in mice.
    Boquist L
    Acta Endocrinol (Copenh); 1980 May; 94(1):84-8. PubMed ID: 6992491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The protective effect of Amomum xanthoides extract against alloxan-induced diabetes through the suppression of NFkappaB activation.
    Park BH; Park JW
    Exp Mol Med; 2001 Jun; 33(2):64-8. PubMed ID: 11460883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the selectivity of alloxan for the beta-cells of the islets of Langerhans: effect of pH on the in vitro action of alloxan.
    Watkins D; Cooperstein SJ; Fiel S
    J Pharmacol Exp Ther; 1979 Feb; 208(2):184-9. PubMed ID: 33262
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of alloxan on islet tissue permeability: protection and reversal by dithiols.
    Watkins D; Cooperstein SJ
    J Pharmacol Exp Ther; 1976 Dec; 199(3):575-82. PubMed ID: 792416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of 1.25-dihydroxycholecalciferol, parathormone and Ca2+ on the pancreatic B-cell sensitivity to alloxan.
    Boquist L; Hagström S; Strindlund L
    Acta Pathol Microbiol Scand A; 1977 Jul; 85(4):501-10. PubMed ID: 331860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects in vitro of alloxan on the glucose metabolism of mouse pancreatic B-cells.
    Borg LA; Eide SJ; Andersson A; Hellerström C
    Biochem J; 1979 Sep; 182(3):797-802. PubMed ID: 391224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in the blood glucose response of mice to alloxan and alloxan-inhibiting compounds.
    Boquist L
    Acta Endocrinol (Copenh); 1979 Dec; 92(4):687-93. PubMed ID: 532524
    [No Abstract]   [Full Text] [Related]  

  • 34. Stereological study of B-cell mitochondria in alloxan-treated mice.
    Lorentzon R; Boquist L
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1979; 31(3):227-33. PubMed ID: 43016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alloxan cytotoxicity in vitro. Inhibition of rubidium ion pumping in pancreatic beta-cells.
    Idahl LA; Lernmark A; Sehlin J; Täljedal IB
    Biochem J; 1977 Jan; 162(1):9-18. PubMed ID: 192215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative toxicity of alloxan, N-alkylalloxans and ninhydrin to isolated pancreatic islets in vitro.
    Jörns A; Munday R; Tiedge M; Lenzen S
    J Endocrinol; 1997 Nov; 155(2):283-93. PubMed ID: 9415063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bioelectrical properties of pancreatic islet cells: effects of diabetogenic agents.
    Dean PM; Matthews EK
    Diabetologia; 1972 Jul; 8(3):173-8. PubMed ID: 4261686
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of a low dose of alloxan on blood glucose, islet beta cell granulation, body weight, and insulin resistance of ob/ob mice.
    Solomon J; Bulkley RJ; Mayer J
    Diabetologia; 1974 Dec; 10(6):709-15. PubMed ID: 4613592
    [No Abstract]   [Full Text] [Related]  

  • 39. Interactions of diabetogenic compounds: cyproheptadine and alloxan.
    Chatterjee AK; Varayotha V; Fischer LJ
    Fundam Appl Toxicol; 1991 Jan; 16(1):188-97. PubMed ID: 2019344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the mechanism of glucose protection against alloxan toxicity.
    Scheynius A; Täljedal IB
    Diabetologia; 1971 Aug; 7(4):252-5. PubMed ID: 4937446
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.